$SRI
STONERIDGE INC Stock $sri

$sri Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000104333723000038 Filed on May 03, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$266.8M	$241.3M
YoY Change	20.77%	9.17%
Cost Of Revenue	$205.9M	$198.5M
YoY Change	12.89%	10.53%
Gross Profit	$60.94M	$42.80M
YoY Change	58.02%	3.28%
Gross Profit Margin	22.84%	17.74%
Selling, General & Admin	$32.05M	$29.86M
YoY Change	10.74%	8.99%
% of Gross Profit	52.59%	69.77%
Research & Development	$22.65M	$16.97M
YoY Change	45.63%	-0.35%
% of Gross Profit	37.17%	39.64%
Depreciation & Amortization	$8.646M	$8.325M
YoY Change	1.31%	-4.38%
% of Gross Profit	14.19%	19.45%
Operating Expenses	$54.70M	$46.83M
YoY Change	22.94%	5.41%
Operating Profit	$6.241M	-$4.029M
YoY Change	-205.28%	35.02%
Interest Expense	-$3.449M	$2.746M
YoY Change	-383.4%	53.75%
% of Operating Profit	-55.26%
Other Income/Expense, Net	-$2.387M	-$1.148M
YoY Change	-500.5%	-13.75%
Pretax Income	-$1.505M	-$8.094M
YoY Change	-78.27%	30.93%
Income Tax	$1.487M	-$708.0K
% Of Pretax Income
Net Earnings	-$2.992M	-$7.386M
YoY Change	-59.23%	-3.77%
Net Earnings / Revenue	-1.12%	-3.06%
Basic Earnings Per Share	-$0.11	-$0.27
Diluted Earnings Per Share	-$0.11	-$0.27
COMMON SHARES
Basic Shares Outstanding	27.51M shares	27.35M shares
Diluted Shares Outstanding	27.45M shares	27.35M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.71M	$35.17M
YoY Change	-14.71%	-15.04%
Cash & Equivalents	$34.71M	$35.17M
Short-Term Investments
Other Short-Term Assets	$43.28M	$43.60M
YoY Change	-15.55%	-13.77%
Inventory	$175.3M	$168.7M
Prepaid Expenses
Receivables	$185.3M	$175.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$438.6M	$423.1M
YoY Change	10.81%	6.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$118.5M	$107.6M
YoY Change	12.66%	-1.39%
Goodwill	$34.87M	$34.66M
YoY Change	3.97%	-2.13%
Intangibles	$46.64M	$45.59M
YoY Change	1.55%	-7.57%
Long-Term Investments	$46.95M	$46.42M
YoY Change	10.35%	6.51%
Other Assets
YoY Change
Total Long-Term Assets	$246.9M	$247.6M
YoY Change	1.76%	-2.73%
TOTAL ASSETS
Total Short-Term Assets	$438.6M	$423.1M
Total Long-Term Assets	$246.9M	$247.6M
Total Assets	$685.5M	$670.7M
YoY Change	7.37%	3.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$136.5M	$132.0M
YoY Change	24.98%	28.6%
Accrued Expenses	$75.58M	$68.55M
YoY Change	12.62%	-3.75%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$171.6M	$1.456M
YoY Change	4007.16%	-71.91%
Total Short-Term Liabilities	$383.6M	$202.0M
YoY Change	112.58%	12.82%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$16.25M	$6.750M
YoY Change	170.9%	18.05%
Total Long-Term Liabilities	$16.25M	$192.5M
YoY Change	-91.24%	8.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$383.6M	$202.0M
Total Long-Term Liabilities	$16.25M	$192.5M
Total Liabilities	$407.9M	$394.5M
YoY Change	11.47%	10.53%
SHAREHOLDERS EQUITY
Retained Earnings	$191.3M	$194.3M
YoY Change	-4.69%	-6.62%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$277.6M	$276.2M
YoY Change
Total Liabilities & Shareholders Equity	$685.5M	$670.7M
YoY Change	7.37%	3.06%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$2.992M	-$7.386M
YoY Change	-59.23%	-3.77%
Depreciation, Depletion And Amortization	$8.646M	$8.325M
YoY Change	1.31%	-4.38%
Cash From Operating Activities	$4.494M	-$9.182M
YoY Change	125.49%	-53.65%
INVESTING ACTIVITIES
Capital Expenditures	$7.915M	$8.911M
YoY Change	36.94%	20.94%
Acquisitions
YoY Change
Other Investing Activities	$374.0K	$1.355M
YoY Change	-88.93%	926.52%
Cash From Investing Activities	-$7.541M	-$8.755M
YoY Change	81.97%	20.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.042M	-$2.119M
YoY Change	-17.02%	-87.64%
NET CHANGE
Cash From Operating Activities	4.494M	-$9.182M
Cash From Investing Activities	-7.541M	-$8.755M
Cash From Financing Activities	3.042M	-$2.119M
Net Change In Cash	-5.000K	-$19.63M
YoY Change	-100.33%	-55.54%
FREE CASH FLOW
Cash From Operating Activities	$4.494M	-$9.182M
Capital Expenditures	$7.915M	$8.911M
Free Cash Flow	-$3.421M	-$18.09M
YoY Change	-9.66%	-33.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001043337
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-13337
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	STONERIDGE, INC
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	34-1598949
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	39675 MacKenzie Drive, Suite 400
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Novi
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48377
CY2023Q1	dei	City Area Code CityAreaCode	248
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	489-9300
CY2023Q1	dei	Security12g Title Security12gTitle	Common Shares
CY2023Q1	dei	Trading Symbol TradingSymbol	SRI
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27513330	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35165000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54798000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	853000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	962000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	175666000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	158155000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	168701000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	152580000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	43604000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	44018000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	423136000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	409551000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107591000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104643000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45585000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45508000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	34659000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	34225000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13352000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13762000	usd
CY2023Q1	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	46415000	usd
CY2022Q4	us-gaap	Investments And Other Noncurrent Assets InvestmentsAndOtherNoncurrentAssets	44416000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	247602000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	242554000	usd
CY2023Q1	us-gaap	Assets Assets	670738000	usd
CY2022Q4	us-gaap	Assets Assets	652105000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1456000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1450000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	131996000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	110202000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	68547000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	66040000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	201999000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	177692000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	167393000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	167802000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8310000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8498000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10043000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10594000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6750000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6577000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	192496000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	193471000	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-99302000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-103142000	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28966000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28966000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27513000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27341000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	225956000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	232758000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1453000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1625000	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	44717000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	50366000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	194306000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	201692000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	276243000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	280942000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	670738000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	652105000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	241325000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	221058000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	198523000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	179615000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	29863000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27399000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16968000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17028000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4029000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2984000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2746000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1786000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-171000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-81000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1148000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1331000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8094000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6182000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-708000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1493000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7386000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-7675000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27349000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27199000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27349000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27199000	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7386000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-7675000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4072000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	4161000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-232000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1048000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3840000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5209000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3546000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2466000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	144000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-62000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	279000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7386000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-7675000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6573000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	6877000	usd
CY2023Q1	sri	Amortization And Accretion Of Debt Discount AmortizationAndAccretionOfDebtDiscount	1946000	usd
CY2022Q1	sri	Amortization And Accretion Of Debt Discount AmortizationAndAccretionOfDebtDiscount	2357000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2536000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-605000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-171000	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-81000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	886000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	94000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	69000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1098000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-34000	usd
CY2022Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-265000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16833000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7236000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6129000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15228000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9812000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1943000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12842000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	21264000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	6581000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1687000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	87000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9182000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19811000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	10110000	usd
CY2022Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	7368000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1355000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	132000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8755000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	8000000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	8568000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	16000000	usd
CY2023Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	8148000	usd
CY2022Q1	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	9834000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	8475000	usd
CY2022Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	10311000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1224000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	669000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2119000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17146000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	423000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-19633000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-44159000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54798000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85547000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35165000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41388000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	2494000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1435000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2611000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1491000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	295950000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-7675000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1048000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	4161000	usd
CY2022Q1	sri	Repurchased Common Shares For Treasury RepurchasedCommonSharesForTreasury	-4093000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-3653000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	293924000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	280942000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-7386000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-232000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	4072000	usd
CY2023Q1	sri	Repurchased Common Shares For Treasury RepurchasedCommonSharesForTreasury	-5649000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-6802000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	276243000	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform to their 2023 presentation in the condensed consolidated financial statements.</span></div>
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	241325000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	221058000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	0	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2023Q1	us-gaap	Weighted Average Cost Inventory Amount WeightedAverageCostInventoryAmount	14498000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	132302000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	121983000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9414000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7812000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	26985000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	22785000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	168701000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	152580000	usd
CY2023Q1	us-gaap	Fifo Inventory Amount FIFOInventoryAmount	154203000	usd
CY2022Q4	us-gaap	Fifo Inventory Amount FIFOInventoryAmount	139996000	usd
CY2022Q4	us-gaap	Weighted Average Cost Inventory Amount WeightedAverageCostInventoryAmount	12584000	usd
CY2022Q2	sri	Payments For Earn Out Consideration From Operating And Financing Activities PaymentsForEarnOutConsiderationFromOperatingAndFinancingActivities	8272000	usd
CY2022Q2	sri	Payments For Earn Out Consideration PaymentsForEarnOutConsideration	6276000	usd
CY2023Q1	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet	0	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	292860	shares
CY2023Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1456000	usd
CY2022Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	1450000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1456000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1450000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	218727	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27349357	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27198677	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27349357	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27198677	shares
CY2023Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	4069000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	229000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3840000	usd
CY2022Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	5287000	usd
CY2022Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	78000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5209000	usd
CY2023Q1	us-gaap	Accrual For Environmental Loss Contingencies Charges To Expense For New Losses AccrualForEnvironmentalLossContingenciesChargesToExpenseForNewLosses	125000	usd
CY2022Q1	us-gaap	Accrual For Environmental Loss Contingencies Charges To Expense For New Losses AccrualForEnvironmentalLossContingenciesChargesToExpenseForNewLosses	0	usd
CY2023Q1	us-gaap	Accrual For Environmental Loss Contingencies Gross AccrualForEnvironmentalLossContingenciesGross	278000	usd
CY2022Q4	us-gaap	Accrual For Environmental Loss Contingencies Gross AccrualForEnvironmentalLossContingenciesGross	246000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	4979000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	4437000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	13477000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	9846000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4329000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	3058000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	141000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	0	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2025000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2992000	usd
CY2023Q1	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	66000	usd
CY2022Q1	us-gaap	Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-94000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	15988000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	9818000	usd
CY2023Q1	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	1262000	usd
CY2022Q1	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	34000	usd
CY2023Q1	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	1262000	usd
CY2022Q1	us-gaap	Restructuring And Related Cost Incurred Cost RestructuringAndRelatedCostIncurredCost	34000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1786000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8911000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-708000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.087
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1493000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.242
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	241325000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	221058000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4029000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2984000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8325000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8706000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2746000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7368000	usd
CY2023Q1	us-gaap	Assets Assets	670738000	usd
CY2022Q4	us-gaap	Assets Assets	652105000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	241325000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	221058000	usd
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	247602000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	242554000	usd
CY2023Q1	us-gaap	Increase Decrease In Fair Value Adjustments On Assets And Liabilities Carried At Fair Value Under Fair Value Option IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption	-171000	usd
CY2022Q1	us-gaap	Increase Decrease In Fair Value Adjustments On Assets And Liabilities Carried At Fair Value Under Fair Value Option IncreaseDecreaseInFairValueAdjustmentsOnAssetsAndLiabilitiesCarriedAtFairValueUnderFairValueOption	-81000	usd

Files In Submission

Name	View Source	Status
0001043337-23-000038-index-headers.html	Edgar Link	pending
0001043337-23-000038-index.html	Edgar Link	pending
0001043337-23-000038.txt	Edgar Link	pending
0001043337-23-000038-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sri-20230331.htm	Edgar Link	pending
sri-20230331.xsd	Edgar Link	pending
sri-20230331xexx103drspgra.htm	Edgar Link	pending
sri-20230331xexx104ltipper.htm	Edgar Link	pending
sri-20230331xexx105ltipres.htm	Edgar Link	pending
sri-20230331xexx311.htm	Edgar Link	pending
sri-20230331xexx312.htm	Edgar Link	pending
sri-20230331xexx321.htm	Edgar Link	pending
sri-20230331xexx322.htm	Edgar Link	pending
sri-20230331_g1.jpg	Edgar Link	pending
sri-20230331_cal.xml	Edgar Link	unprocessable
sri-20230331_def.xml	Edgar Link	unprocessable
sri-20230331_lab.xml	Edgar Link	unprocessable
sri-20230331_pre.xml	Edgar Link	unprocessable
sri-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SRI
STONERIDGE INC Stock $sri

2023 Q2 Form 10-Q Financial Statement

#000104333723000038 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SRI STONERIDGE INC Stock $sri

2023 Q2 Form 10-Q Financial Statement

#000104333723000038 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SRI
STONERIDGE INC Stock $sri